Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

The Second Hospital of Tianjin Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients who meet the diagnostic criteria of cough variant asthma and TCM syndrome.
•2. The patient's age was > 18 years old and < 65 years old, and the course of disease was more than 6 weeks.
•3. Not taking drugs or taking the drugs specified in the guidelines for diagnosis and treatment of cough (2015);
•4. The patients who had taken traditional Chinese medicine for CVA were observed after two weeks of withdrawal;
•5. After stopping inhaling glucocorticoids, bronchodilators and other drugs to reduce airway hyperresponsiveness, the patients with positive bronchodilation test and cough as the main symptoms were detected 24 hours later;
•6. Patients who are willing to cooperate with this clinical study and sign informed consent.

•1. Typical asthma, esophageal reflux disease, pharyngitis, etc.
•2. Pregnant or lactating women, or patients who are allergic to the drug in this study.
•3. Patients with mental disorders, behavioral disorders, or severe hearing problems and who are considered to be impaired or illiterate and unable to cooperate.
•4. Patients with severe pulmonary heart disease, respiratory failure or other serious organ dysfunction.
•5. Patients who have used other Chinese and Western medicines for cough treatment or are participating in clinical research of other drugs after the onset of the disease.
•6. Patients with poor compliance with traditional Chinese and Western medicine treatment.

发起方